These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 233672

  • 1. Pituitary-adrenal axis activity in treated congenital adrenal hyperplasia: static and dynamic studies.
    Pham-Huu-Trung MT, Gourmelen M, Raux-Eurin MC, Girard F.
    J Clin Endocrinol Metab; 1978 Aug; 47(2):422-7. PubMed ID: 233672
    [Abstract] [Full Text] [Related]

  • 2. Comparison of basal and adrenocorticotropin-stimulated plasma 21-deoxycortisol and 17-hydroxyprogesterone values as biological markers of late-onset adrenal hyperplasia.
    Fiet J, Gueux B, Gourmelen M, Kuttenn F, Vexiau P, Couillin P, Pham-Huu-Trung MT, Villette JM, Raux-Demay MC, Galons H.
    J Clin Endocrinol Metab; 1988 Apr; 66(4):659-67. PubMed ID: 2831244
    [Abstract] [Full Text] [Related]

  • 3. The hypothalamic-pituitary-adrenal axis in partial (late-onset) 21-hydroxylase deficiency.
    Feuillan P, Pang S, Schürmeyer T, Avgerinos PC, Chrousos GP.
    J Clin Endocrinol Metab; 1988 Jul; 67(1):154-60. PubMed ID: 2837498
    [Abstract] [Full Text] [Related]

  • 4. Pituitary-adrenal responses to corticotropin-releasing hormone in different degrees of adrenal 21-hydroxylase deficiency.
    Moreira AC, Elias LL.
    J Clin Endocrinol Metab; 1992 Jan; 74(1):198-203. PubMed ID: 1309366
    [Abstract] [Full Text] [Related]

  • 5. Plasma aldosterone concentrations related to 17alpha-hydroxyprogesterone in congenital adrenal hyperplasia.
    Pham-Huu-Trung MT, Raux MC, Gourmelen M, Baron MC, Girard F.
    Acta Endocrinol (Copenh); 1976 Jul; 82(3):572-86. PubMed ID: 180741
    [Abstract] [Full Text] [Related]

  • 6. Absence of nonclassical congenital adrenal hyperplasia in patients with precocious adrenarche.
    Morris AH, Reiter EO, Geffner ME, Lippe BM, Itami RM, Mayes DM.
    J Clin Endocrinol Metab; 1989 Oct; 69(4):709-15. PubMed ID: 2550505
    [Abstract] [Full Text] [Related]

  • 7. Increased plasma 21-deoxycorticosterone (21-DB) levels in late-onset adrenal 21-hydroxylase deficiency suggest a mild defect of the mineralocorticoid pathway.
    Fiet J, Gueux B, Raux-DeMay MC, Kuttenn F, Vexiau P, Brerault JL, Couillin P, Galons H, Villette JM, Julien R.
    J Clin Endocrinol Metab; 1989 Mar; 68(3):542-7. PubMed ID: 2537337
    [Abstract] [Full Text] [Related]

  • 8. 17-Hydroxyprogesterone in the cosyntropin test: results in normal and hirsute women and in mild congenital adrenal hyperplasia.
    Gourmelen M, Pham-Huu-Trung MT, Bredon MG, Girard F.
    Acta Endocrinol (Copenh); 1979 Mar; 90(3):481-9. PubMed ID: 218414
    [Abstract] [Full Text] [Related]

  • 9. Augmented 17 alpha-hydroxyprogesterone response to ACTH stimulation as evidence of decreased 21-hydroxylase activity in patients with incidentally discovered adrenal tumours ('incidentalomas').
    Seppel T, Schlaghecke R.
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):445-51. PubMed ID: 7955456
    [Abstract] [Full Text] [Related]

  • 10. 17-Hydroxyprogesterone responses to adrenocorticotropin in children with premature adrenarche.
    Granoff AB, Chasalow FI, Blethen SL.
    J Clin Endocrinol Metab; 1985 Mar; 60(3):409-15. PubMed ID: 2982895
    [Abstract] [Full Text] [Related]

  • 11. Serum cortisol and 17-hydroxyprogesterone interrelation in classic 21-hydroxylase deficiency: is current replacement therapy satisfactory?
    Charmandari E, Matthews DR, Johnston A, Brook CG, Hindmarsh PC.
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4679-85. PubMed ID: 11600525
    [Abstract] [Full Text] [Related]

  • 12. Pituitary-ovarian responses to leuprolide acetate testing in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Ghizzoni L, Virdis R, Vottero A, Cappa M, Street ME, Zampolli M, Ibañez L, Bernasconi S.
    J Clin Endocrinol Metab; 1996 Feb; 81(2):601-6. PubMed ID: 8636275
    [Abstract] [Full Text] [Related]

  • 13. Detection of late-onset adrenal hyperplasia in girls with peripubertal virilization.
    Sólyom J, Gács G, Keszei K, Láng K, Orley J, Petheö I, Ságodi L.
    Acta Endocrinol (Copenh); 1987 Jul; 115(3):413-8. PubMed ID: 3039770
    [Abstract] [Full Text] [Related]

  • 14. Attenuated forms of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Lee PA, Rosenwaks Z, Urban MD, Migeon CJ, Bias WD.
    J Clin Endocrinol Metab; 1982 Nov; 55(5):866-71. PubMed ID: 6288754
    [Abstract] [Full Text] [Related]

  • 15. Angiotensin and adrenal steroidogenesis: study of 21-hydroxylase-deficient congenital adrenal hyperplasia.
    Schaison G, Couzinet B, Gourmelen M, Elkik F, Bougneres P.
    J Clin Endocrinol Metab; 1980 Dec; 51(6):1390-4. PubMed ID: 7002950
    [Abstract] [Full Text] [Related]

  • 16. 17-Hydroxyprogesterone response to ACTH in bilateral and monolateral adrenal incidentalomas.
    Bernini GP, Brogi G, Vivaldi MS, Argenio GF, Sgrò M, Moretti A, Salvetti A.
    J Endocrinol Invest; 1996 Dec; 19(11):745-52. PubMed ID: 9061508
    [Abstract] [Full Text] [Related]

  • 17. [Salivary 17-hydroxyprogesterone concentration in monitoring of the treatment of congenital adrenal hyperplasia].
    Arisaka O, Shimura N, Nakayama Y, Arisaka M, Yabuta K.
    Dtsch Med Wochenschr; 1988 Dec 09; 113(49):1913-5. PubMed ID: 3197614
    [Abstract] [Full Text] [Related]

  • 18. Adrenal function in hirsutism I. Diurnal change and response of plasma androstenedione, testosterone, 17-hydroxyprogesterone, cortisol, LH and FSH to dexamethasone and 1/2 unit of ACTH.
    Givens JR, Andersen RN, Ragland JB, Wiser WL, Umstot ES.
    J Clin Endocrinol Metab; 1975 Jun 09; 40(6):988-1000. PubMed ID: 166091
    [Abstract] [Full Text] [Related]

  • 19. Pituitary-adrenocortical function in abdominal obesity of males: evidence for decreased 21-hydroxylase activity.
    Hautanen A, Adlercreutz H.
    J Steroid Biochem Mol Biol; 1996 Apr 09; 58(1):123-33. PubMed ID: 8809194
    [Abstract] [Full Text] [Related]

  • 20. Incidental adrenal nodules: association with exaggerated 17-hydroxyprogesterone response to adrenocorticotropic hormone.
    Turton DB, O'Brian JT, Shakir KM.
    J Endocrinol Invest; 1992 Dec 09; 15(11):789-96. PubMed ID: 1337905
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.